We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$188M
AUM Growth
+$30.7M
Cap. Flow
+$18.4M
Cap. Flow %
9.8%
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$962K
2
PLD icon
Prologis
PLD
+$773K
3
BKNG icon
Booking.com
BKNG
+$734K
4
ETN icon
Eaton
ETN
+$720K
5
TEL icon
TE Connectivity
TEL
+$708K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Financials 20.16%
3 Technology 16.46%
4 Industrials 8.76%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLX icon
401
Amylyx Pharmaceuticals
AMLX
$2.19B
$73.4K 0.04%
25,849
+3,719
+17% +$48.6K
TGTX icon
402
TG Therapeutics
TGTX
$8.19B
$73.2K 0.04%
4,815
-328
-6% -$5.22K
ALXO icon
403
ALX Oncology
ALXO
$262M
$73.2K 0.04%
6,566
-453
-6% -$6.36K
NVAX icon
404
Novavax
NVAX
$1.21B
$72.8K 0.04%
15,228
-1,043
-6% -$4.84K
RLAY icon
405
Relay Therapeutics
RLAY
$4B
$72.2K 0.04%
8,702
-593
-6% -$5.79K
CRBU icon
406
Caribou Biosciences
CRBU
$146M
$72.2K 0.04%
14,044
-961
-6% -$5.93K
CABA icon
407
Cabaletta Bio
CABA
$427M
$71.9K 0.04%
4,215
-292
-6% -$6.27K
ABCL icon
408
AbCellera Biologics
ABCL
$1.65B
$71.6K 0.04%
15,812
-1,082
-6% -$5.52K
TNGX icon
409
Tango Therapeutics
TNGX
$4.21B
$67.5K 0.04%
8,502
-584
-6% -$6.26K
AGEN
410
Agenus
AGEN
$276M
$66K 0.04%
5,691
-390
-6% -$5.17K
IMVT icon
411
Immunovant
IMVT
$7.93B
$65.6K 0.03%
2,031
-143
-7% -$5.22K
ALEC icon
412
Alector
ALEC
$169M
$65.2K 0.03%
10,829
-744
-6% -$4.87K
GPCR icon
413
Structure Therapeutics
GPCR
$3.37B
$63.4K 0.03%
1,480
-100
-6% -$4.22K
EDIT icon
414
Editas Medicine
EDIT
$399M
$59.3K 0.03%
7,990
-551
-6% -$4.58K
FLNA
415
Filana Therapeutics
FLNA
$42M
$58.4K 0.03%
2,879
-196
-6% -$4.52K
QURE icon
416
uniQure
QURE
$2.78B
$55.6K 0.03%
10,693
-737
-6% -$4.23K
PRTA icon
417
Prothena Corp
PRTA
$448M
$55.1K 0.03%
2,223
-150
-6% -$4.46K
CVAC
418
DELISTED
CureVac
CVAC
$45.4K 0.02%
14,988
-1,030
-6% -$3.62K
RAPT
419
DELISTED
RAPT Therapeutics
RAPT
$40.2K 0.02%
560
-38
-6% -$5.28K
ALLK
420
DELISTED
Allakos
ALLK
$34.7K 0.02%
27,504
-1,887
-6% -$2.93K
SCLX icon
421
Scilex Holding
SCLX
$46.1M
$26.6K 0.01%
504
ADP icon
422
Automatic Data Processing
ADP
$109B
-2,423
Closed -$564K
AEM icon
423
Agnico Eagle Mines
AEM
$72.2B
-4,124
Closed -$226K
ALCO icon
424
Alico
ALCO
$280M
-7,861
Closed -$229K
ALEX
425
DELISTED
Alexander & Baldwin
ALEX
-11,939
Closed -$227K

Similar funds

Virtus ETF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus ETF Advisers held 495 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $18.4M of net new capital in Q1 2024, opening 69 new positions and adding to 189 existing holdings. Its largest new stake was Host Hotels & Resorts: 47,997 shares worth $993K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $569K trimmed.

  • Virtus ETF Advisers's largest Q1 2024 buy was Host Hotels & Resorts: 47,997 shares worth $993K.
  • Virtus ETF Advisers added most to BlackRock TCP Capital in Q1 2024, an estimated $1.06M increase.
  • Virtus ETF Advisers's biggest Q1 2024 reduction was ConocoPhillips, cutting an estimated $569K.
  • Virtus ETF Advisers fully exited Burlington in Q1 2024, selling an estimated $962K.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $188M portfolio in Q1 2024.
  • Virtus ETF Advisers opened 69 new positions and closed 73 in Q1 2024.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $188M.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.